Mirati Therapeutics reported $1.23B in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agios Pharmaceuticals AGIO:US USD 784.94M 85.07M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 219.21M
Amgen AMGN:US USD 24.06B 4.74B
Astellas Pharma 4503:JP JPY 1.06T 69.86B
AstraZeneca AZN:LN USD 20.22B 693M
Bayer BAYN:GR EUR 38.41B 1.14B
Bluebird Bio BLUE:US USD 160.44M 7.02M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Eisai 4523:JP JPY 585.38B 35.57B
Eli Lilly And LLY:US USD 17.64B 524.7M
Exelixis EXEL:US USD 1.84B 10.02M
Gilead Sciences GILD:US USD 13.9B 723M
GlaxoSmithKline GSK:LN GBP 20.25B 33.94B
Moderna Inc MRNA:US USD 14.3B 734M
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Novartis NOVN:VX USD 36.95B 1.19B
Puma Biotechnology PBYI:US USD 122.35M 8.07M
Sarepta Therapeutics SRPT:US USD 2.63B 156.63M
Seattle Genetics SGEN:US USD 2.76B 19.04M
Spectrum Pharmaceuticals SPPI:US USD 112.98M 39.4M
Takeda 4502:JP JPY 2.75T 196.1B
Ultragenyx Pharmaceutical RARE:US USD 1.01B 334.13M
YTE INCY:US USD 3.82B 195.27M